Top 10 evidence-based essentials in infectious disease - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Top 10 evidence-based essentials in infectious disease

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

  • By

  • MDSpire News Staff

  • August 18, 2026

  • 4 min

Share

Clinical Report: Top 10 evidence-based essentials in infectious disease

Background

Infectious diseases pose significant health challenges, necessitating up-to-date clinical guidelines and evidence-based practices. The integration of major treatment guidelines, antimicrobial resistance guidance, and pivotal trials is crucial for effective patient management.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

  • IDSA guidance on antimicrobial-resistant Gram-negative infections addresses treatment for various resistant pathogens.
  • IDSA updated its COVID-19 treatment guidelines with nine revised recommendations based on systematic reviews.
  • CDC recommends doxycycline postexposure prophylaxis for men who have sex with men and transgender women to prevent STIs.
  • The DoxyPEP trial showed doxycycline reduced rates of STIs compared to standard care.
  • Cefepime-taniborbactam demonstrated higher success rates in treating complicated urinary tract infections compared to meropenem in the CERTAIN-1 trial.
  • CDC guidance includes lenacapavir as an HIV preexposure prophylaxis option based on trial data.

Clinical Implications

Clinicians should stay informed about the latest guidelines and trial results to optimize treatment strategies for infectious diseases. The integration of these evidence-based practices can enhance patient outcomes and address emerging challenges in antimicrobial resistance.

Related Resources & Content

  1. Infectious Diseases Society of America, IDSA 2026 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
  2. ClinicalInfo.HIV.gov, Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV
  3. MDSpire News — Top 10 Evidence-Based Essentials in Dermatology
  4. MDSpire News — Top 10 Evidence-Based Essentials in Internal Medicine
  5. MDSpire News — Top 10 Evidence-Based Essentials in Family Medicine
  6. MDSpire News — Top 10 Evidence-Based Essentials in Neurology
  7. Top 10 Evidence-Based Essentials in Dermatology
  8. Top 10 Evidence-Based Essentials in Internal Medicine
  9. Top 10 Evidence-Based Essentials in Family Medicine
  10. IDSA 2026 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
  11. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV - ClinicalInfo.HIV.gov - NCBI Bookshelf
  12. WHO consolidated guidelines on tuberculosis: module 4: treatment and care

Original Source(s)

Top 10 evidence-based essentials in infectious disease

  • by MDSpire News Staff

  • August 18, 2026

Related Content

Neonatal HSV-1 diversity greater between patients than within patients

Deep sequencing found no significant association between minor-variant burden and disease severity, although several newborns had unusually high within-host viral diversity.

MMRV Use May Reveal Vaccine Access Gaps

The study identified the populations most likely to be affected by reduced access to MMRV.

Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial

An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.